stoxline Quote Chart Rank Option Currency Glossary
  
(PTCT)
  0 (0%)    11-11 19:25
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-11-11 4:49:33 PM
Short term     
Mid term     
Targets 6-month :  86.47 1-year :  101
Resists First :  74.03 Second :  86.47
Pivot price 69.07
Supports First :  67.4 Second :  63.31
MAs MA(5) :  72.48 MA(20) :  68.64
MA(100) :  56.5 MA(250) :  51.36
MACD MACD :  2.4 Signal :  2.1
%K %D K(14,3) :  84 D(3) :  80.5
RSI RSI(14): 74
52-week High :  74.03 Low :  35.95
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PTCT ] has closed below upper band by 2.6%. Bollinger Bands are 29.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 74.13 - 74.4 74.4 - 74.62
Low: 71.16 - 71.51 71.51 - 71.78
Close: 73.3 - 73.83 73.83 - 74.27
Company Description

Headline News

Tue, 11 Nov 2025
Fox Run Management L.L.C. Invests $651,000 in PTC Therapeutics, Inc. $PTCT - MarketBeat

Mon, 10 Nov 2025
Is PTCT stock ready for a breakout - Portfolio Performance Report & Low Drawdown Investment Strategies - newser.com

Sun, 09 Nov 2025
Is PTCT stock ready for breakout - Trade Volume Report & Real-Time Volume Trigger Notifications - newser.com

Sat, 08 Nov 2025
PTC Therapeutics (PTCT) Is Up 5.1% After Return to Profitability and Strong Sephience Launch – Has The Bull Case Changed? - simplywall.st

Sat, 08 Nov 2025
PTCT FY2025 EPS Forecast Raised by Cantor Fitzgerald - MarketBeat

Fri, 07 Nov 2025
Assessing PTC Therapeutics (PTCT) Valuation Following Strong Earnings Turnaround and Updated Revenue Guidance - simplywall.st

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 79 (M)
Shares Float 65 (M)
Held by Insiders 2.4 (%)
Held by Institutions 101.1 (%)
Shares Short 7,820 (K)
Shares Short P.Month 7,290 (K)
Stock Financials
EPS 7.05
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.6
Profit Margin 35.6 %
Operating Margin -19.5 %
Return on Assets (ttm) 23.8 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -4.2 %
Gross Profit (p.s.) 15.23
Sales Per Share 22.15
EBITDA (p.s.) 11.26
Qtrly Earnings Growth 0 %
Operating Cash Flow 705 (M)
Levered Free Cash Flow 518 (M)
Stock Valuations
PE Ratio 10.47
PEG Ratio 0
Price to Book value -28.4
Price to Sales 3.33
Price to Cash Flow 8.32
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android